Studies conducted with cell lines derived from lung cancer, pancreatic cancer, and hepatocellular carcinoma have demonstrated that the decoupling of KEAP1–NRF2 alters proliferation dynamics. This evidence concerns the gene NFE2L2 and pancreatic neoplasm.